Xander Bertels
YOU?
Author Swipe
View article: Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024
Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024 Open
In April 2024, the European Summit “ Raising the bar in respiratory care” was organized by the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) in the European Parliament and hosted by Members of the Europ…
View article: European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned
European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned Open
The European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized the first European Biologic Training Course (EBTC) in Brussels on 1st March 2024. The aim of this hybrid EBTC including both face-to-face and…
View article: Impact of Respiratory and Cardiovascular Drug Exposure on Lung Function Trajectories
Impact of Respiratory and Cardiovascular Drug Exposure on Lung Function Trajectories Open
Rationale: Research suggests that respiratory and cardiovascular drugs can ameliorate the rate of lung function decline. Objectives: To investigate the impact of respiratory and cardiovascular pharmacotherapy on lung function trajectories …
View article: Exploring the genetics of airflow limitation in lung function across the lifespan – a polygenic risk score study
Exploring the genetics of airflow limitation in lung function across the lifespan – a polygenic risk score study Open
This study was supported by CADSET, a Clinical Research Collaboration of the European Respiratory Society.
View article: Clinical relevance of lung function trajectory clusters in middle-aged and older adults
Clinical relevance of lung function trajectory clusters in middle-aged and older adults Open
Background The determinants and health outcomes of lung function trajectories in adults among the general population are poorly understood. We aimed to identify and characterise clusters of lung function trajectories in adults aged ≥45 yea…
View article: Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaboration
Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaboration Open
Background The prevalence and clinical profile of asthma with airflow obstruction (AO) remain uncertain. We aimed to phenotype AO in population- and clinic-based cohorts. Methods This cross-sectional multicohort study included adults ≥50 y…
View article: The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study
The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study Open
Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek, FWO). Background Although non-vitamin K antagonist oral antic…
View article: Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study
Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study Open
Background: Although non-vitamin K antagonist oral anticoagulants (NOACs) are recommended over vitamin K antagonists (VKAs) in atrial fibrillation (AF) management, direct long-term head-to-head comparisons are lacking. Therefore, their ris…
View article: The implementation of risk minimization measures to prevent teratogenic pregnancy outcomes related to oral retinoid and valproate use in Belgium
The implementation of risk minimization measures to prevent teratogenic pregnancy outcomes related to oral retinoid and valproate use in Belgium Open
Both oral retinoid and valproate containing medicines are highly teratogenic. Their use by women of childbearing age is controlled by risk minimization measures (RMMs) introduced by the European Medicine Agency, including the pregnancy pre…